MANTENGOLI, ELISABETTA
 Distribuzione geografica
Continente #
NA - Nord America 1.146
EU - Europa 858
AS - Asia 229
AF - Africa 13
OC - Oceania 1
SA - Sud America 1
Totale 2.248
Nazione #
US - Stati Uniti d'America 1.139
RU - Federazione Russa 404
IE - Irlanda 127
IT - Italia 122
SE - Svezia 92
SG - Singapore 64
HK - Hong Kong 59
CN - Cina 41
CH - Svizzera 29
FI - Finlandia 29
DE - Germania 27
IN - India 25
TR - Turchia 25
GB - Regno Unito 15
JO - Giordania 13
CI - Costa d'Avorio 12
BE - Belgio 9
CA - Canada 7
RS - Serbia 2
AU - Australia 1
BR - Brasile 1
EG - Egitto 1
HR - Croazia 1
IR - Iran 1
KR - Corea 1
UA - Ucraina 1
Totale 2.248
Città #
Fairfield 137
Dublin 127
Chandler 99
Woodbridge 85
Ashburn 80
Ann Arbor 73
Cambridge 68
Santa Clara 67
Wilmington 62
Houston 59
Seattle 57
Singapore 55
Princeton 33
Buffalo 32
Hong Kong 30
Bern 29
Boston 27
Florence 26
Izmir 23
Moscow 20
Lawrence 19
Mumbai 19
New York 19
Altamura 17
Beijing 17
Munich 16
Boardman 15
San Diego 13
Abidjan 12
Brussels 9
Shanghai 8
Jacksonville 7
Toronto 7
Cagliari 6
Helsinki 6
Medford 6
Norwalk 5
San Vincenzo 5
Bologna 4
Chennai 4
Kent 4
Sant'elpidio A Mare 4
Siena 4
Washington 4
Bremen 3
Modena 3
Prato 3
Rome 3
Andover 2
Arnsberg 2
Campi Bisenzio 2
Hillsboro 2
Kragujevac 2
Los Angeles 2
Molfetta 2
Naples 2
Quinto Vicentino 2
Redmond 2
Sesto San Giovanni 2
Arezzo 1
Avellino 1
Baoding 1
Bastia 1
Bethesda 1
Bettolle 1
Cairo 1
Cedar Knolls 1
Changsha 1
Chicago 1
Council Bluffs 1
Dallas 1
Falls Church 1
Frankfurt Am Main 1
Hangzhou 1
Henderson 1
Landshut 1
Laurel 1
London 1
Misano di Gera d'Adda 1
Monmouth Junction 1
Pune 1
Redwood City 1
San Jose 1
Secunderabad 1
Selargius 1
Seoul 1
Shenyang 1
São Paulo 1
Tehran 1
Wandsworth 1
Wenzhou 1
Xiamen 1
Yubileyny 1
Zhengzhou 1
Totale 1.488
Nome #
Evaluation of candidemia and antifungal consumption in a large tertiary care Italian hospital over a 12-year period 127
Cell-mediated and humoral adaptive immune responses to SARS-CoV-2 are lower in asymptomatic than symptomatic COVID-19 patients 113
Antibiotic usage and risk of colonization and infection with antibiotic-resistant bacteria: a hospital population-based study 110
Antipneumococcal activity of ulifloxacin compared to levofloxacin and ciprofloxacin 99
Antimicrobial resistance in Europe and its potential impact on empirical therapy 99
Arbo-score: A rapid score for early identification of patients with imported arbovirosis caused by Dengue, Chikungunya and zika virus 95
Risk factors for bloodstream infections due to colistin-resistant KPC-producing Klebsiella pneumoniae: Results from a multicenter case-control-control study 92
Successful tigecycline lock therapy in a Lactobacillus rhamnosus catheter-related bloodstream infection 91
Epidemiology and clinical relevance of microbial resistance determinants versus anti-Gram-positive agents 83
Seroprevalence of West Nile and dengue virus in the human population of the Bolivian Chaco 80
Information technology systems to support antimicrobial stewardship programs 73
Cellulitis caused by a methicillin-sensitive Staphylococcus aureus isolate harboring Panton-Valentine toxin in an American soldier returning from Iraq 73
Molecular epidemiology and clinical feature of infections caused by extended-spectrum beta-lactamase- and AmpC-producing Enterobacteriaceae in a large, multicentric, observational study 72
The effect of leadership on hand hygiene: assessing hand hygiene adherence prior to patient contact in 2 infectious disease units in Tuscany. 70
First-dose mRNA vaccination is sufficient to reactivate immunological memory to SARS-CoV-2 in subjects who have recovered from COVID-19 67
The effect of merging two infectious disease units on hand hygiene adherence in Italy 67
Escherichia coli ST131 producing extended-spectrum β-lactamases plus VIM-1 carbapenemase: further narrowing of treatment options 62
Treatment and control of severe infections caused by multi-resistant Pseudomonas aeruginosa 59
Characterization of Tn5393d, a complex Tn5393 Derivative Carrying the PER-1 Extended-Spectrum beta-Lactamase Gene and Other Resistance Determinants 58
Epidemiology and genetic characteristics of extended-spectrum β-lactamase-producing gram-negative bacteria causing urinary tract infections in long-term care facilities 56
SARS-CoV-2 infection and vaccination trigger long-lived B and CD4+ T lymphocytes: implications for booster strategies 52
In vitro synergism of ulifloxacin plus piperacillin/tazobactam against clinical isolates of Enterobacteriaceae producing extended-spectrum or AmpC-type beta-lactamases 50
Dynamics of a nosocomial outbreak of multidrug-resistant Pseudomonas aeruginosa producing the PER-1 extended-spectrum beta-lactamase 48
Spread in an Italian Hospital of a Clonal Acinetobacter baumannii Strain Producing the TEM-92 Extended-Spectrum beta-Lactamase 48
Nosocomial outbreak by NDM-1-producing Klebsiella pneumoniae highly resistant to cefiderocol, Florence, Italy, August 2021 to June 2022 47
Double Synergy Differential Test (DSDT) for detection of plasmid mediated AmpC-type beta-lactamases in Proteus mirabilis 47
Spread of multidrug-resistant Proteus mirabilis isolates producing an AmpC-type β-lactamase: epidemiology and clinical management 47
Skin IL-17A and IFN-γ Production Correlate with Disease Severity in Patients with Psoriasis and Streptococcal Infection 41
Epidemiology of infections caused by multiresistant Gram-negatives: ESBLs, MBLs, panresistant strains 39
A novel tetrabranched antimicrobial peptide which neutralizes bacterial lipopolysaccharide and prevents septic shock in vivo 39
Epidemiology and genetic characteristics of extended-spectrum beta-lactamase-producing Gram-negative bacteria causing urinary tract infections in long-term care facilities 35
PER-1 extended-spectrum beta-lactamase production in an Alcaligenes faecalis clinical isolate resistant to expanded-spectrum cephalosporins and monobactams from a hospital in Northern Italy 33
Spread of multidrug-resistant Proteus mirabilis isolates producing an AmpC-type beta-lactamase: epidemiology and clinical management 33
Multifocal Detection of Multidrug-Resistant Pseudomonas aeruginosa Producing the PER-1 Extended-Spectrum beta-Lactamase in Northern Italy 29
A Questionnaire Integrated with the Digital Medical Record Improved the Coverage of a Control Program for Congenital Chagas Disease in Tuscany, Italy 22
Ceftazidime-Avibactam Use for Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae Infections: A Retrospective Observational Multicenter Study 13
Totale 2.269
Categoria #
all - tutte 8.327
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.327


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020208 0 0 0 0 35 29 36 31 30 22 16 9
2020/2021187 11 13 3 11 10 32 7 16 17 26 23 18
2021/2022226 9 24 17 14 1 10 7 24 4 13 40 63
2022/2023532 56 61 36 30 50 108 63 20 57 8 10 33
2023/2024214 11 25 37 11 10 38 7 50 2 9 8 6
2024/2025619 55 160 82 256 66 0 0 0 0 0 0 0
Totale 2.269